These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 21344412

  • 21. Effect of PLGA hydrophilia on the drug release and the hypoglucemic activity of different insulin-loaded PLGA microspheres.
    Presmanes C, de Miguel L, Espada R, Alvarez C, Morales E, Torrado JJ.
    J Microencapsul; 2011; 28(8):791-8. PubMed ID: 21967461
    [Abstract] [Full Text] [Related]

  • 22. A sulfate polysaccharide/TNF-related apoptosis-inducing ligand (TRAIL) complex for the long-term delivery of TRAIL in poly(lactic-co-glycolic acid) (PLGA) microspheres.
    Kim H, Jeong D, Kang HE, Lee KC, Na K.
    J Pharm Pharmacol; 2013 Jan; 65(1):11-21. PubMed ID: 23215683
    [Abstract] [Full Text] [Related]

  • 23. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
    Chaisri W, Ghassemi AH, Hennink WE, Okonogi S.
    Colloids Surf B Biointerfaces; 2011 Jun 01; 84(2):508-14. PubMed ID: 21353499
    [Abstract] [Full Text] [Related]

  • 24. Preparation of porous PLGA microspheres with thermoreversible gel to modulate drug release profile of water-soluble drug: bleomycin sulphate.
    Chaudhari KR, Shah N, Patel H, Murthy R.
    J Microencapsul; 2010 Jun 01; 27(4):303-13. PubMed ID: 20128747
    [Abstract] [Full Text] [Related]

  • 25. In Vitro and In Vivo preparation evaluations of bleomycin implants and microspheres Prepared with DL-poly (lactide-co-glycolide).
    D'Souza R, Mutalik S, Udupa N.
    Drug Dev Ind Pharm; 2006 Feb 01; 32(2):175-84. PubMed ID: 16537198
    [Abstract] [Full Text] [Related]

  • 26. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity.
    Kim TH, Jiang HH, Park CW, Youn YS, Lee S, Chen X, Lee KC.
    J Control Release; 2011 Feb 28; 150(1):63-9. PubMed ID: 21062635
    [Abstract] [Full Text] [Related]

  • 27. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S, Shi Y, Li L, Xu J, Schaper A, Kissel T.
    Eur J Pharm Biopharm; 2008 Feb 28; 68(2):214-23. PubMed ID: 17651954
    [Abstract] [Full Text] [Related]

  • 28. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX, Shi YN, Teng LS, Li X, Wang LX, Meng QF, Teng LR, Li YX.
    Pharm Dev Technol; 2011 Aug 28; 16(4):377-84. PubMed ID: 20370594
    [Abstract] [Full Text] [Related]

  • 29. Injectable Sustained-Release Depots of PLGA Microspheres for Insoluble Drugs Prepared by hot-Melt Extrusion.
    Guo Y, Yang Y, He L, Sun R, Pu C, Xie B, He H, Zhang Y, Yin T, Wang Y, Tang X.
    Pharm Res; 2017 Oct 28; 34(10):2211-2222. PubMed ID: 28741064
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy.
    Lim SM, Eom HN, Jiang HH, Sohn M, Lee KC.
    J Pharm Sci; 2015 Jan 28; 104(1):72-80. PubMed ID: 25407390
    [Abstract] [Full Text] [Related]

  • 31. Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel.
    Ozeki T, Kaneko D, Hashizawa K, Imai Y, Tagami T, Okada H.
    Int J Pharm; 2012 May 10; 427(2):299-304. PubMed ID: 22366485
    [Abstract] [Full Text] [Related]

  • 32. Influence of formulation composition and process on the characteristics and in vitro release from PLGA-based sustained release injectables.
    Meeus J, Scurr DJ, Appeltans B, Amssoms K, Annaert P, Davies MC, Roberts CJ, Van den Mooter G.
    Eur J Pharm Biopharm; 2015 Feb 10; 90():22-9. PubMed ID: 25448071
    [Abstract] [Full Text] [Related]

  • 33. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
    Doan TV, Couet W, Olivier JC.
    Int J Pharm; 2011 Jul 29; 414(1-2):112-7. PubMed ID: 21596123
    [Abstract] [Full Text] [Related]

  • 34. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
    Jeong YI, Na HS, Seo DH, Kim DG, Lee HC, Jang MK, Na SK, Roh SH, Kim SI, Nah JW.
    Int J Pharm; 2008 Mar 20; 352(1-2):317-23. PubMed ID: 18160236
    [Abstract] [Full Text] [Related]

  • 35. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
    Zhang H, Lu Y, Zhang G, Gao S, Sun D, Zhong Y.
    Int J Pharm; 2008 Mar 03; 351(1-2):244-9. PubMed ID: 18024022
    [Abstract] [Full Text] [Related]

  • 36. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2009 Nov 01; 74(1):340-9. PubMed ID: 19717287
    [Abstract] [Full Text] [Related]

  • 37. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y, Pan J, Feng SS.
    Int J Pharm; 2010 Aug 16; 395(1-2):243-50. PubMed ID: 20472049
    [Abstract] [Full Text] [Related]

  • 38. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS, Carson KH, Rice-Ficht AC, Andrews MJ.
    Int J Pharm; 2007 Jun 07; 337(1-2):118-26. PubMed ID: 17289316
    [Abstract] [Full Text] [Related]

  • 39. Effect of additives on the release of a model protein from PLGA microspheres.
    Kang F, Singh J.
    AAPS PharmSciTech; 2001 Dec 17; 2(4):30. PubMed ID: 14727867
    [Abstract] [Full Text] [Related]

  • 40. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K, Kabasawa T, Ozeki T, Okada H.
    J Control Release; 2009 Apr 02; 135(1):19-24. PubMed ID: 19121349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.